Polly Goodman, CIP; Michael Linke, PhD, CIP; Nichelle Cobb, PhD
CNY Biotech Accelerator
In 2018, the National Institutes of Health issued a policy requiring single IRB review for most multisite research. Now FDA is considering changing its rules to make single IRB review the expectation for most multisite research. This session will explore single IRB requirements and their implications for adapting this new IRB landscape. Click here to register.
Wednesday, August 2, 2023
| 3:00 PM - 4:00 PM
| via Zoom Questions? Contact: durdonk@upstate.edu
Thank you for visiting the research website. Your feedback is valuable to us as we strive to support researchers and provide information about the exciting research conducted at Upstate Medical University.
In 2018, the National Institutes of Health issued a policy requiring single IRB review for most multisite research. Now FDA is considering changing its rules to make single IRB review the expectation for most multisite research. This session will explore single IRB requirements and their implications for adapting this new IRB landscape. Click here to register.